Trial
NCT02501278
A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
Inovio Pharmaceuticals; Centre Hospitalier Universitaire Vaudois
Condition
Uterine Cervical Neoplasms
Intervention
INO-3112 vaccine
Why stopped
company (Inovio) is no longer able to support the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-13